Clinical Trial Update: Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intranasal mometasone for obstructive sleep apnea in children has been withdrawn. The withdrawal indicates the study is no longer ong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Nasonex (mometasone furoate)

Snippet

Sponsor: Children's & Women's Health Centre of British Columbia | Conditions: Obstructive Sleep Apnea (Mild, Moderate, Severe) as Per Polysomnography | Phase 3 | Status: WITHDRAWN